Home > About Osteosarcoma > References

References

References

  1. Bielack SS, Bernstein ML. Osteosarcoma in “Cancer in children: clinical management”, Oxford University Press, 5th edition, 2005, page 280
  2. Bielack SS, Kempf-Biealck B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities of trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002, 20, 776-790
  3. Bieling P, Rehan N, Winkler P, et al. Tumour size and prognosis in aggressively treated osteosarcoma. J Clin Oncol 1996, 14, 848-858
  4. Whelan J, Weeden S, Uscinska B, et al, Localized extremity osteosarcoma: Mature survival data from two European Osteosarcoma Intergroup randomised clinical trials. Proceedings of the American Society of Clinical Oncology 2000,19,1281a
  5. Friedman MA, Carter SK, “The therapy of osteogenic sarcoma: current status and thoughts for the future”, J. Surg.Oncol, 1972:4(5):482-510
  6. Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics 1985;8:659-664
  7. Rosen G, Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12). Prog Clin Clin Biol Res 1985;201:39-51
  8. Winkler K et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian Study, JCO, vol 2, 6(June), 1984
  9. Smeland S et al. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders. Eur J Cancer. 2003 Mar;39(4):488-94
  10. Cortes EP, Holland JF, Wang JJ, et al. Amputation and adriamycin in primary osteosarcoma, N Engl J Med. 1974; 291:998-1000
  11. Pratt CB, Shanks EC Doxorubicin in treatment of malignant solid tumours Am J Dis Child. 1974;127:534-536
  12. Baum ES, Gaynon P, Greenberg L et al. Phase II trial cisplatin in refractory childhood cancer: Children’s Cancer Study Group Report. Cancer Treat Rep. 1981; 65:815-822
  13. Gasparini M, Rouesse J, van OA, et al Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer, Soft Tissue and Bone Sarcoma Group. Cancer Treat Rep. 1985; 69:211-213
  14. Ochs JJ, Freeman AI, Douglass HO, et al. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep. 1978; 62:239-245
  15. Jaffe N, Frei E, Traggis D, et al. Adjuvant methotrexate and citrovorum factor treatment of osteogenic sarcoma. N Engl J Med. 1974; 291:994-997
  16. Pratt CB, Roberts D, Shanks EC, et al,. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate – “leucovorin rescue” for children with malignant tumours. Cancer Res. 1974;34:3326-3331
  17. Pratt CB,Howarth C, Ransom JL, et al. High-dose methotrexate used alone and in combination for measurable primary or metastatic osteosarcoma. Cancer Treat Rep. 1980;64:11-20
  18. de KJ, Voute PA. Ifosfamide, mesna and vincristine in paediatric oncology. Cancer Treat Rev. 1983;10 Suppl A:165-6:165-166
  19. Marti C, Kroner T, Remagen W, et al. High-dose ifosfamide in advanced osteosarcoma. Cancer Treat Rep. 1985;69:115-117
  20. Miser JS, Kinsella TJ, Triche TJ, et al. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol. 1987;5:1191-1198
  21. Saleh RA, Graham-Pole J, Cassano W, et al. Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy. Cancer. 1990;65:861-865
  22. Einhorn S, Strander H. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J Gen Virol 1977; 35:573-7
  23. Hofmann V, Groscurth P, Morant R, et al. Effects of leukocyte interferon (E. coli) on human bone sarcoma growth in vitro and in the nude mouse. Eur J Cancer Clin Oncol 1985; 21:859-63
  24. Brosjo O. Osteosarcoma and interferon. Studies of human xenografts in the nude mouse. Acta Orthop Scand Suppl 1989; 229:1-36
  25. Adamson A, Aparisi T, Brostrom LA: Interferon treatment of osteosarcoma. Pontificiae Acad Scient Scripta Varia 1979; 43:383-406
  26. Strander H, Bauer HC, Brosjo O, et al. Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study. Acta Oncol 1995; 34:877-80
  27. Muller CR, Smeland S, Bauer HC, et al. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series. Acta Oncol 2005; 44:475-80

< Go back to the About Osteosarcoma Homepage